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Palmitoylation is the reversible addition of palmitate to cysteine via a thioester linkage. The
reversible nature of this modification makes it a prime candidate as a mechanism for reg-
ulating signal transduction in T-cell receptor signaling. Following stimulation of the T-cell
receptor we find a number of proteins are newly palmitoylated, including those involved in
vesicle-mediated transport and Ras signal transduction. Among these stimulation-dependent
palmitoylation targets are the v-SNARE VAMP7, important for docking of vesicular LAT
during TCR signaling, and the largely undescribed palmitoyl acyltransferase DHHC18 that is
expressed in two isoforms in T cells. Using our newly developed On-Plate Palmitoylation
Assay (OPPA), we show DHHC18 is capable of palmitoylating VAMP7 at Cys183. Cellular
imaging shows that the palmitoylation-deficient protein fails to be retained at the Golgi and to
localize to the immune synapse upon T cell activation.
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The initial signaling events following the recognition of apeptide-MHC complex on an antigen-presenting cell(APC) by the T-cell receptor (TCR) involve a number of
important molecules that must localize to the plasma membrane
(PM) at the immunological synapse (IS). Palmitoylation, the
reversible linking of 16-carbon palmitic acid to cysteines via a
labile thioester bond, is one strategy used by several important
TCR-signaling proteins to drive this localization to and from the
membrane (e.g., the soluble Src-family kinases Lck and Fyn) or to
and from liquid-ordered microdomains (“lipid rafts”) within the
membrane (e.g., the transmembrane scaffold LAT)1.
Unlike other lipid modifications like myristoylation or pre-
nylation, the reversible chemistry of the thioester bond allows
palmitoylation to be both added to and removed from specific
cysteines; indeed, enzymes have evolved to both add (e.g., the
DHHC family of protein acyltransferases [PATs]) and remove
(e.g., acyl protein thioesterase 1 [APT1] and ABHD17) palmitate
from these sites in eukaryotes2,3. This has given rise to palmi-
toylation cycles, where proteins are palmitoylated in the ER/
Golgi, cycled to the PM via vesicle trafficking and localized to the
site of activity, then depalmitoylated and recycled back to the ER/
Golgi4.
Such cycles have become well established in neuronal proteins
like PSD-95, as well as the G-protein α subunits Gαi and Gαq and
small GTPases H-Ras and N-Ras4,5, and pulse-chase experiments
have shown that palmitoylation turnover can be accelerated fol-
lowing signaling stimuli, such as glutamate receptor activation
with PSD-95, GTP binding of H-Ras, and GPCR signaling for Gα
proteins6–8. In the context of T-cells, Lck has been shown to
undergo relatively rapid palmitate turnover under resting con-
ditions, which is accelerated following Fas receptor stimulation,
and this palmitoylation is specifically catalyzed by DHHC21 at
the PM9. A decrease in the palmitoylation of LAT has been
observed in anergic T cells, which affects its ability to localize to
lipid rafts and induce an effective stimulatory response1,10.
Docking of vesicular LAT to the IS and downstream signaling
also critically depend on palmitoylated SNARE proteins like
SNAP-23 and VAMP711,12. While these targeted approaches
suggest the possibility of regulated palmitoylation cycles, a global
approach tracking changes of the complete palmitome of T cells
following a stimulatory event has not been reported.
Equally enigmatic are the enzymes responsible for catalyzing
the palmitoylation reaction, the DHHC family of PATs, first
identified in yeast more than 15 years ago13,14. While 23 PATs are
expressed in mammals, due to the challenges inherent in
expressing and purifying these multi-pass membrane proteins,
only a handful of mammalian PATs have been investigated
in vitro: the palmitoylation of Gαi by DHHC2 and DHHC3, the
palmitoylation of PSD-95 by DHHC15, and the autopalmitoyla-
tion of DHHC9 and DHHC2015–19. These studies often rely on
the use of [3H]-palmitic acid to quantify the palmitoylated sub-
strate, requiring long exposure times and the hazards of radio-
active materials, or else are limited to the kinetics of the
autopalmitoylation reaction using enzyme-linked assays or pal-
mitoylation targets of peptide length. We here developed the on-
plate palmitoylation assay (OPPA) method as a rapid, click
chemistry-based approach to quantifying an intact palmitoylated
substrate over time.
The understanding of palmitoylated SNARE proteins has
generally been restricted to those lacking transmembrane
domains (TMDs), such as SNAP-25 and the vesicular SNARE
Ykt6, where the addition of hydrophobic palmitate assists in
membrane recruitment20. However, the vesicular synaptobrevin-
family SNARE protein VAMP7, despite featuring a single TMD at
its C-terminus, has been reported to be palmitoylated in a large
number of different mammalian global palmitome studies21–30.
The observation that many of the proteins found to be palmi-
toylated are in fact integral membrane proteins (up to ~50–60%
of proteins enriched by ABE) suggests the mechanism of regu-
lated palmitoylation is subtler than the simpler model of mem-
brane recruitment31. Possible reasons why a transmembrane
protein might be palmitoylated include the mediation of protein-
protein interactions within the membrane, the induction of
conformational changes (e.g., “tilting” within the membrane or
the recruitment of soluble tails to the membrane), the driving of
localization to liquid-ordered microdomains within the mem-
brane, or as an interplay with other post-translation modifications
like ubiquitin32. The palmitoylation of VAMP7 might represent a
new mode of transmembrane SNARE protein palmitoylation
beyond the relatively straightforward membrane recruitment seen
in the soluble SNARE proteins, allowing an additional layer of
subtlety to its regulation.
Results and discussion
The T-cell palmitome composition changes on TCR stimula-
tion. Using the acyl-biotin exchange (ABE) method with SILAC-
labeled Jurkat T-cell lysates allowed us to quantify the T-cell
palmitome via quantitative LC-MS/MS (Fig. 1a)31. We previously
reported the ABE-enriched Jurkat palmitome under resting
conditions31; here we reanalyze these data with a volcano plot-
based approach, allowing us to identify 115 high-confidence
palmitoylation candidates, including well-established palmitoy-
lated proteins like Lck and LAT (Fig. 1b). This allows for the-
direct comparison to the Jurkat palmitome 10 min following anti-
CD3/anti-CD28 costimulation (Fig. 1c and d, Suppemen-
tary Fig. 1). After stimulation, 169 proteins are found in the high-
confidence palmitoylated pool. Three criteria were used for vali-
dation (Fig. 1e): number of previous reports in 13 human pal-
mitome studies, number of predicted palmitoylation
sites (CSSPalm 4.0), and number of predicted transmem-
brane domains (TMDs) (TMHMM 2.0); we see an over-
representation of all three criteria in our enriched pools versus
background unenriched proteins, confirming the
enrichment27,28,30,31,33–43.
Directly comparing these two pools of proteins reveals 94
constitutively palmitoylated proteins, 18 stimulation-dependent
depalmitoylated proteins, and 70 stimulation-dependent modified
proteins (Supplementary Data 1). Lck and LAT are constitutively
palmitoylated, while among the stimulation-dependent palmi-
toylated proteins are the v-SNARE protein VAMP7 and the PAT
DHHC18. VAMP7 belongs to the synaptobrevin family of v-
SNAREs, and has been shown to be crucial for docking vesicular
LAT to the IS and downstream signaling events in CD4+
T cells11. DHHC18 is a Golgi-localized PAT, and although it has
been described to palmitoylate H-Ras44,45, little is known about
its enzymatic properties or substrate specificity19. As autopalmi-
toylation is the initial step in the PAT enzymatic mechanism46,
finding this PAT palmitoylated after TCR stimulation presumably
represents an activated state of this enzyme, and may hint at an
upregulation of specific PAT activity following TCR stimulation.
Of the stimulation-dependent palmitoylation candidates,
approximately half are transmembrane proteins. Grouping the
protein interaction networks using STRING analysis reveals a
large cluster of Gα, Ras, and Ras-related proteins (Fig. 2a).
Intriguingly, within this cluster are GNAI3, GNAO1, and
GNAI1/2, all of which feature N-terminal myristoylation motifs,
while the Gα proteins GNAQ and GNA13, both of which lack a
myristoylation motif, are found to be constitutively palmitoylated.
This could suggest an interplay between co-translational
myristoylation and post-translational, stimulation-dependent
palmitoylation, in which myristoylated Gα proteins are
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preferentially palmitoylated following TCR stimulation. Indeed,
the stimulation-dependent palmitoylation targets feature a slight
enrichment of proteins containing myristoylation motifs (8.8%)
versus constitutively palmitoylated proteins (6.4%), perhaps
hinting at a larger trend. Functionally, the stimulation-
dependent palmitoylation candidates are involved in a variety
of cellular processes (Fig. 1g), notably Ras signal transduction,
TCR-signaling, and vesicle-mediated transport.
Rapid determination of palmitoylation rates by OPPA. To
investigate these stimulation-dependent palmitoylation candi-
dates in a controlled setting, we designed constructs of DHHC18,
DHHC20, VAMP7, and LAT for expression in Sf9 insect cells
(Fig. 2A, Supplementary Figs. 4, 5). Although VAMP7 has been
reported as palmitoylated in eight other human palmitome
studies23,24,27,28,30,38,39,43,47, the site of its palmitoylation has not
been described. Of the six cysteines in its primary sequence, we
found three NEM-modified during our ABE enrichment (data
not shown), suggesting they are not palmitoylated, while two
others are located in the vesicular lumen, not accessible to a
DHHC PAT’s cytosolic active site; the remaining cysteine,
Cys183, which is located in an optimal juxtamembrane position,
























COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-1063-5 ARTICLE
COMMUNICATIONS BIOLOGY |           (2020) 3:368 | https://doi.org/10.1038/s42003-020-1063-5 | www.nature.com/commsbio 3
Likewise, in DHHC18, we sought to investigate the role the N-
and C-terminal tails of DHHC18 might play in the enzyme’s
stability or activity by designing ΔN and ΔC domain constructs.
Moreover, we designed a construct based on the truncated isoform
2 of DHHC18, which we previously hypothesized was preferentially
palmitoylated in T cells31. Intriguingly, this isoform lacks the two
N-terminal TMDs of the full-length protein, yet features a cysteine
(Cys138) only three residues from its new N-terminus, which might
represent a palmitoylation anchor to the membrane.
In order to improve upon the shortcomings of current
in vitro palmitoylation assays, we developed the OPPA method
(Fig. 2B). Briefly, purified substrates (e.g., VAMP7) bearing
both His6- and FLAG-tags are bound to Ni-NTA plates,
to which purified DHHC PATs (lacking His6-tags) and
clickable palmitic acid alkyne (PAA)-CoA are added. The
palmitoylation reaction is quenched at specific time points by
N-ethylmaleimide (NEM), which both blocks the site of
palmitoylation and the DHHC active-site cysteine. After
washing, biotin-azide is clicked onto the palmitoylated
substrate, which is subsequently eluted from the Ni-NTA plate
and bound to anti-FLAG-coated plates. This allows the
detection of the biotinylated substrate via fluorescence of Eu3
Fig. 1 Enrichment of Jurkat T-cell palmitome before and after anti-CD28/anti-CD3-costimulation by acyl-biotin exchange. a Schematic representation
of acyl-biotin exchange (ABE) protocol coupled with SILAC for quantitation of palmitoylated proteins via LC-MS/MS. Briefly, Jurkat cells grown in heavy
SILAC media (blue) were lysed and free thiols were blocked with NEM. After cleaving palmitoyl groups with HA, previously palmitoylated thiols are
biotinylated with HPDP-biotin, allowing for streptavidin enrichment. For control cells grown in light SILAC media (red), HA is omitted, preventing
biotinylation. Proteins quantified with heavy/light intensity ratios >2.0 are considered enriched and palmitoylated. b Volcano plot showing high-confidence
palmitoylated proteins prior to stimulation (n= 6, p < 0.05). Proteins found in five or more other palmitome studies are highlighted in orange. c Volcano
plot showing high-confidence palmitoylated proteins 10min after anti-CD28/anti-CD3 costimulation (n= 4, p < 0.05). d Comparison of high-confidence
palmitoylated pools before and after stimulation. Only proteins from b and c that displayed a p-value < 0.05 are considered. These p-values and additional
statistical parameters are detailed in Supplementary Data 1. e Analysis of palmitoylated proteins compared to unenriched (background) proteins, with three
metrics: at least five references in previous palmitome studies, at least one predicted palmitoylation site (CSSPalm 4.0, high cutoff), and at least one
predicted transmembrane domain (TMHMM 2.0). f STRING functional analysis of proteins enriched for palmitoylation 10 min after TCR stimulation. A
clear cluster of Gα and Ras-related proteins is observed. Several interesting candidates are highlighted, including VAMP7 and DHHC18, which were
investigated in more detail in this study. g Gene Ontology (GO) term enrichment of stimulation-dependent palmitoylation candidates, generated using
BiNGO. Cluster size indicates the number of genes in each node, while color indicates statistical significance of enrichment.
Fig. 2 In vitro palmitoylation of VAMP7 by DHHC18 and DHHC20. a Schematic cartoon of constructs used, with important cysteines highlighted. Cys222
and Cys15 are the active sites of DHHC18 and DHHC20, respectively. Cys183 in VAMP7 is the site of palmitoylation. b Cartoon model of potential
membrane docking of DHHC18 isoform 2 via Cys138. The full-length DHHC18 features the two N-terminal TMDs, securing the DHHC active site to the
membrane. The short isoform, lacking these TMDs, may be anchored to the membrane via palmitoylation of Cys138, allowing its active-site access to the
membrane environment required for its activity. c Schematic representation of the on-plate palmitoylation assay (OPPA). Briefly, the target (VAMP7,
featuring both His6 and FLAG-tags) is bound to a Ni-NTA plate. The DHHC PAT is added with clickable PAA-CoA and the reaction is quenched at specific
time points using NEM. Biotin is subsequently clicked on to the PAA-modified target, VAMP7 is eluted and then bound to an anti-FLAG plate. Streptavidin-
Eu3+ can then be used to quantify palmitoylated VAMP7, and a steady-state slope can be calculated. d Results of OPPA experiments of VAMP7-WT and
VAMP7-C183A, palmitoylated by constructs of DHHC18 and DHHC20 (n≥ 12, geometric mean ± SEM shown).
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+-streptavidin and the determination of the steady-state rate of
palmitoylation.
Examining DHHC18 and DHHC20 activity by OPPA. Using
the VAMP7 and LAT constructs as palmitoylation targets and the
DHHC18 and DHHC20 constructs as palmitoylating enzymes
allowed us to validate the OPPA method and investigate these
reactions in vitro (Fig. 2c). While autopalmitoylation of VAMP7
is minimal at 20 µM PAA-CoA (Supplementary Figs. 6–8), the
rate of palmitoylation is greatly enhanced by full-length
DHHC18. The active-site mutant DHHC18-C222A prevents
this palmitoylation. DHHC20 was barely capable of palmitoy-
lating VAMP7, while its active-site mutant C156A is also inactive.
Truncating either the N- or C-terminal tails of DHHC18
results in a significant decrease in the palmitoylation rate of
VAMP7. Whether this speaks for a role of these cytosolic tails in
substrate recognition or engagement, in its enzymatic mechan-
ism, or in simply stabilizing the enzyme will require further
investigation. The short isoform DHHC18-2, lacking the N-
terminal TMDs, is capable of palmitoylating VAMP7, albeit at a
slightly decreased rate. Intriguingly, mutating the proposed
palmitoylation anchor cysteine C138 to alanine prevents
DHHC18-2’s palmitoylation of VAMP7, while this mutation in
full-length DHHC18-1 has no effect; one potential model to
explain this is shown in Fig. 2b.
Finally, LAT was used as a second palmitoylation target. Full-
length DHHC18 was capable of palmitoylating LAT, while
DHHC20 failed to do so. This may speak to a specificity for LAT
palmitoylation by DHHC18 and not DHHC20. As DHHC20 is
located at the PM and turnover of LAT palmitoylation is not
expected to be rapid, the specificity of Golgi-localized DHHC18
could perhaps reflect a biological reality; this should be confirmed
in a cellular context, perhaps with PAT-specific knockouts and
subsequent palmitome enrichment, as was recently performed for
DHHC1345,48.
VAMP7 palmitoylation is required for its localization. The
proposed palmitoylation site in VAMP7, Cys183, was also
mutated to alanine. This prevented its palmitoylation by both
DHHC18 and DHHC20, suggesting that this is indeed the pri-
mary site of in vitro palmitoylation. To confirm this in vivo,
CRISPR/Cas9-knockout Jurkat cell lines with lentivirally trans-
duced stable re-expression of VAMP7-WT and -C183 A con-
structs were engineered (Supplementary Fig. 10). Once generated,
ABE was used to enrich all palmitoylated proteins in these cell
lines. VAMP7 was found to be palmitoylated in the Jurkat E6.1
and VAMP7-WT re-expression cell lines, but not in the VAMP7-
knockout or VAMP7-C183A re-expression cell lines, confirming
that Cys183 is the site of VAMP7 palmitoylation in Jurkat T cells
(Supplementary Fig. 11).
The VAMP7-KO Jurkat cell lines stably expressing VAMP7-
WT and VAMP7-C183A were analyzed by confocal microscopy
to observe localization of these two constructs. The re-expressed
VAMP7-WT, which is capable of being palmitoylated, is largely
found in the Golgi of the VAMP7-knockout/re-expression Jurkat
cells, in agreement with earlier observations (Fig. 3a)49. VAMP7-
C183A, however, does not colocalize with the Golgi marker
giantin, instead localizing to the cytosol, presumably within
vesicles (Fig. 3). This supports the conclusion that palmitoylation
of VAMP7 at Cys183 acts as a sorting signal for the Golgi50,51.
Mutating Cys183 prevents this localization, allowing a larger
population of VAMP7 to localize to vesicles11,52. Since it was
shown previously that VAMP7 is localized to the immune
synapse upon TCR activation11,52,53, we tested if the palmitoyla-
tion of VAMP7 can affect its recruitment. We analyzed the
enrichment of VAMP7-WT and VAMP7-C183A in VAMP7-
knockout/re-expressing Jurkat cells upon conjugate formation
with Raji B cells. The Raji cells were left unpulsed or pulsed with
the activating superantigen staphylococcus enterotoxin E (SEE)
that binds and activates the TCR expressed by Jurkat cells.
Quantification of the confocal microscopy images, as shown
previously11 showed that VAMP7-WT was enriched at the
immune synapse in the presence of SEE (Fig. 3c, +SEE and
average density map representation in a “mean cell” Fig. 3d and
quantification in 3e). In contrast, the VAMP7-C138A mutant was
fully compromised and did not get enriched at the immune
synapse.
Altogether these results suggest that the palmitoylation of
VAMP7 controls its localization in the Golgi at steady state and
its recruitment to the immune synapse upon T-cell activation.
Since VAMP7 has been shown to control membrane trafficking to
and from the Golgi54, mislocalization of the mutant form of
VAMP7 may have downstream consequences for T-cell function
such as polarized transport of proteins or cell migration. The fact
that, as shown here, localization of this key v-SNARE protein is
regulated upon TCR triggering reinforces the link that exists
between TCR-induced signaling and intracellular trafficking55.
Conclusions
In this study we capitalize on a proteomic screen for palmitoy-
lated proteins that identifies clusters of G proteins, of vesicular
transport proteins and of the DHHC palmitoyl transferases
themselves. An OPPA was developed to probe the palmitoylation
of individual sites in the palmitoyl acyltransferases as well as their
target proteins. We show that VAMP7 can be palmitoylated at
Cysteine-183 by DHHC18 in vitro, and that a palmitoylation-
deficient mutant, VAMP7C183A, when expressed in Jurkat T cells
is localized away from the Golgi. Furthermore, this mutant is
unable to be recruited to the immunological synapse formed
between the T cell and Raji B cells upon superantigen stimulation.
Thus, our screen provides an important basis for further inves-
tigations into the context between T-cell stimulation, DHHC
enzyme activation, and vesicular transport.
Methods
Jurkat cell culture and stimulation. Jurkat T cells (clone E6-1) and Raji B (ATCC,
CCL-86) cells were grown in RPMI 1640 SILAC medium with 10% FCS at 37 °C
and 5% CO2 (SILAC Quantification Kit, Pierce). Jurkat cells were stimulated using
anti-CD3 IgM (C305) and anti-CD28 IgM hybridoma supernatants in RPMI
without FCS at 37 °C; stimulation was quenched after 10 min by the addition of ice-
cold PBS, centrifugation (300 × g, 5 min, 4 °C), and subsequent shock-freezing of
the cell pellets.
Generation of VAMP7-knockout in Jurkat cells. For the generation of sgRNAs
the Atum online tool was used (https://www.dna20.com/eCommerce/cas9/input).
The sgRNA oligos were then cloned into the pSpCas9(BB)-2A-GFP (PX458) vector
(a kind gift from Feng Zhang [Addgene plasmid # 48138; http://n2t.net/
addgene:48138; RRID:Addgene_48138]). Jurkat T cells (clone E6-1) were passaged
to 0.125 Mio cells/ml the day before transfection. Five Mio cells were resuspended
in 100 µl OptiMem with 10 µg pSpCas9(BB)-2A-GFP with the sgRNA CACCG-
CACACCAAGCATGTTTGGCA and electroplated with a NEPA21 electroporator
(Nepagene) with the following settings: 0.2 mm gap electroporation cuvettes,
poring pulse: 175 V, length: 5 ms, interval: 50 ms, number: 2, D. rate: 10%, polarity:
+. After 48 h single clones were sorted by FACS for EGFP into 96-well plates. After
the cells had recovered and grown the knockout was validated by western blotting
and sequencing.
Lentiviral transduction of Jurkat cells. Once the VAMP7-knockout cell line was
validated, the re-expression of VAMP7 constructs was performed. Wildtype
VAMP7 and mutant VAMP7-C183A, both featuring FLAG-tags, were cloned into
the lentiviral vector LegoiG2 (a kind gift from Boris Fehse [Addgene plasmid #
27341; http://n2t.net/addgene:27341; RRID:Addgene_27341])56. HEK293 cells
were transfected with the constructs FLAG-VAMP7-WT-LegoiG2 or FLAG-
VAMP7-C183A-LegoiG2 plus the third-generation packaging plasmids pMDLg/
pRRE with pRSV-Rev and phCMV-VSV-G using lipofectamine. Supernatants
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containing viruses were harvested after 48 h and concentrated by centrifugation at
10,000 × g and 4 °C for 4–6 h in glass tubes. VAMP7-knockout Jurkat cells were
transduced with the viruses by spinoculation, as described previously57. Cells were
resuspended in lentiviral supernatant supplemented with Polybrene (6 µg/ml) and
spun for 90 min at 37 °C at a speed of 800 × g. After 72 h the cells were sorted by
EGFP expression via FACS. One week later the cells were sorted again for EGFP
expression and also for the expression of CD3 and CD28 surface markers.
Construct design and cloning. Primary sequences of VAMP7, LAT, DHHC18,
and DHHC20 were obtained from UniProt. Full-length constructs of VAMP7 and
LAT were engineered bearing His6- and FLAG-tags, while DHHC18 and DHHC20
were designed with FLAG-tags alone, and ordered from Geneart. Truncated con-
structs of DHHC18 were generated by amplifying FLAG-tagged inserts via PCR.
Mutagenesis was performed using the QuikChange Site-Directed Mutagenesis
system (Agilent). Constructs were then cloned into the pFastBac1 vector of the
Bac-to-Bac system (Thermo Fisher).
Insect cell expression and purification. Sf9 insect cells were grown in Sf-900 II
medium (Thermo Fisher) at 27 °C. Baculoviruses were generated by transfecting
insect cells with constructs in the pFastBac1 vector according to the Bac-to-Bac
protocol. P4 viral stocks were then used to infect larger cultures, and expressed
proteins were harvested 3–5 days following infection (~70–80% cell viability).
Cell pellets were shock frozen and lysed in lysis buffer containing 50 mM
NaH2PO4 (pH 7.2) (Roth), 300 mM NaCl (Roth), 0.2% Triton X-100 (Roth), 1
mM phenyl methanesulfonyl fluoride (PMSF) (Sigma), cOmplete protease
inhibitor cocktail (Roche), and DNase (New England BioLabs) and RNase
(Pancreac AppliChem) on ice for 30 min. Lysates were cleared by centrifugation
(16,000 × g, 4 °C, 10 min.) and supernatants were loaded onto anti-FLAG M2
affinity gel (Sigma) at 4 °C. After washing, proteins were eluted using 0.1 M
glycine at pH 3.5 and concentrated using Vivaspin spin filters (VWR) with
appropriate MW cut-offs. After concentration, 0.08% n-dodecyl β-D-maltoside
(DDM) (Sigma) and cOmplete protease inhibitor cocktail was added and
constructs were dialyzed overnight at 4 °C into 50 mM NaH2PO4 (pH 6.5) and
10% glycerol (Roth). Protein concentration was determined by BCA assay
(Pierce) and expression was confirmed by anti-FLAG western blot. Purified
PATs were extremely sensitive to environmental conditions, precipitating at
concentrations greater than ~5–10 µM and losing activity after freezing or
3–5 days storage at 4 °C. For this reason, all purified PATs were used imme-
diately for the OPPA assays following dialysis.
Western blotting. To confirm the stimulation via phosphotyrosine and phospho-
ERK1/2, and to confirm expression/purification of constructs expressed in insect
cells, lysates were run on SDS-PAGE gels and transferred to nitrocellulose mem-
branes using standard methods. Antibodies used for detection: 4G10 Platinum
anti-phosphotyrosine (Millipore), anti-pERK (E-4) (Santa Cruz), anti-β-actin (AC-
15) (Sigma–Aldrich), anti-LAT (Upstate (Millipore)), and anti-FLAG-HRP
(Sigma–Aldrich). The self-produced VAMP7 antibody was a kind gift of Dr.
Andrew Peden (The University of Sheffield, UK).
Fig. 3 The VAMP7-C183A mutant fails to properly localize to the Golgi. a Confocal images showing the relative localization of VAMP7 (red) labelled with
anti-Flag Abs and Giantin (green) in VAMP7-KO Jurkat cells expressing the WT VAMP7-FLAG or the mutant VAMP7-C183A-FLAG proteins. Scale bar 5
μm. b Dot plots showing the quantification of the percentage of Giantin (Golgi marker) overlapping with the VAMP7-FLAG proteins (Manderson
coefficient). Each dot= one cell; horizontal lines=median. ****p < 0.0001 (one-way ANOVA). c Representative confocal images of conjugates of Jurkat
VAMP7-KO cells expressing the WT VAMP7-FLAG or the mutant VAMP7-C183A-FLAG proteins and SEE-pulsed Raji B cells (blue) labeled with anti-FLAG
(VAMP7-FLAG, showed in red) or anti-Giantin (shown in green) antibodies, assessed at 15 min. Scale bar 5 μm. d Mapping and e quantification of the
enrichment of VAMP7 at the immune synapse (depicted by the dotted white line) in Jurkat “mean cells” interacting for 15 min with Raji cells left unpulsed
(−, inactivated state) or pulsed with SEE (+, immune synapse formation). N number of cells constituting the mean image. Horizontal lines represent
median. Scale bar 5 μm. Each dot= one cell; horizontal lines=median. ****p < 0.0001 (t-test and one-way ANOVA). Data are from two independent
experiments.
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Acyl-biotin exchange. The ABE protocol was followed as described
previously31,58. Briefly, stimulated Jurkat SILAC pellets were lysed in lysis buffer
containing 50 mM Tris (pH 7.4) (Roth), 150 mM NaCl (Roth), 10 mM MgCl2
(AppliChem), 10 mM KCl (Sigma–Aldrich), 500 μM EDTA (Roth), 100 μM
Na3VO4 (Sigma–Aldrich), 20 mM NEM (Thermo), 1 mM PMSF, 1.7% Triton
X-100, 1 mM tris(2-carboxyethyl)phosphine (TCEP) (Sigma–Aldrich), 100 μM
methyl arachidonyl fluorophosphonate (MAFP) (Sigma–Aldrich), and cOmplete
protease inhibitor cocktail (PI-cocktail) on ice for 30 min. Lysates were cleared by
centrifugation (16,100 × g, 4 °C, 10 min.). Chloroform-methanol (CM) precipita-
tions were used between each chemical labeling step to ensure complete remove of
unreacted reagents. The cleared lysates were subjected to a CM precipitation, then
resuspended in buffer containing a 50 mM Tris (pH 7.4), 5 mM EDTA, 1% SDS
(Roth), 125 mM NaCl, 1 mM PMSF, 0.2% Triton X-100, 20 mM NEM, and PI-
cocktail and incubated overnight at 4 °C. NEM was then removed by three
sequential CM precipitation steps, and enriched samples (e.g., heavy lysates) were
resuspended in buffer containing 50 mM Tris (pH 7.4), 5 mM EDTA, 125 mM
NaCl, 1% SDS, 574 mM hydroxylamine (HA) (Sigma–Aldrich), 820 µM EZ-Link
HPDP-biotin (Thermo), 0.2% Triton X-100, 1 mM PMSF and PI-cocktail; control
samples (e.g., light lysates) were resuspended in a similar buffer, omitting HA.
After incubation for one hour at room temperature, a single CM precipitation
removed HA, and samples were biotinylated in a buffer containing 50 mM Tris
(pH 7.4), 5 mM EDTA, 125 mM NaCl, 164 µM EZ-Link HPDP-biotin, 0.2% Triton
X-100, 1 mM PMSF, and PI-cocktail for 1 h at room temperature. Samples were
then washed with three sequential CM precipitations and resuspended in buffer
containing 50 mM Tris (pH 7.4), 5 mM EDTA, 125 mM NaCl, 0.1% SDS, 0.2%
Triton X-100, 1 mM PMSF, and PI-cocktail. SILAC-labeled heavy and light sam-
ples were then mixed and allowed to bind to streptavidin-agarose beads (Novagen)
for 90 min at room temperature. After four sequential washings, biotinylated
peptides were eluted by cleaving the HPDP-biotin-cysteine disulfide linkage in a
buffer containing 1% beta-mercaptoethanol (2-ME) (Roth) at 37 °C for 15 min.
Eluates were precipitated via trichloroacetic acid (TCA) precipitation and resus-
pended in a smaller volume of SDS-PAGE sample buffer containing 0.2% Triton X-
100, boiled for 5 min. at 95 °C, then run on a 4–12% Bis-Tris gel (NuPAGE Novex).
After Coomassie staining, gels were used for in-gel tryptic digestion and subsequent
LC-MS/MS. For the stimulated Jurkat cells, four individual ABE enrichments were
performed (n= 4).
Quantitative LC-MS/MS and proteomic data analysis. Coomassie-stained gel
lanes from the ABE enrichment were cut into 30 equal-sized bands and in-gel
tryptic digest was performed as described previously31. Digested peptides were
resuspended in 6 µl 0.1% (v/v) TFA and 5% (v/v) acetonitrile per band. Analysis of
the peptides was performed via reversed-phase capillary liquid chromatography
(Ultimate 3000 nanoLC system (Thermo Scientific)) coupled to an Orbitrap Elite
mass spectrometer (Thermo Scientific). LC separations were performed on a
capillary column (Acclaim PepMap100, C18, 3 μm, 100 Å, 75 μm i.d.×25 cm,
Thermo Scientific) at an eluent flow rate of 300 nL/min using a linear gradient of
3–25% B after 53 min with a further increase to 80% B after 80 min. Mobile phase
A contained 0.1% formic acid in water, and mobile phase B contained 0.1% formic
acid in acetonitrile. Mass spectra were acquired in a data-dependent mode with one
MS survey scan with a resolution of 60,000 (Orbitrap Elite) and MS/MS scans of
the 15 most intense precursor ions in the linear trap quadrupole were used. Raw
data have been deposited at the ProteomeXchange Consortium via the PRIDE
partner repository59.
Identification and SILAC quantification were performed using MaxQuant
software (version 1.4.1.1) with the Uniprot human protein database (2014 release).
Proteins were filtered with the following criteria: (i) not identified only by site,
reverse, or known contaminant (MaxQuant), (ii) at least one unique peptide, and
(iii) at least two razor+ unique peptides. The unstimulated Jurkat ABE enrichment
we published earlier31 (n= 6) was reanalyzed using the following new procedure,
allowing direct comparison to the stimulated Jurkat ABE dataset described here
(n= 4). First, missing values were imputed with the median normalized heavy/light
ratio of the specific LC-MS/MS run—in many cases this was very close to 1.0
(representing the background). H/L ratios were then transformed to log2 values
and the mean H/L ratio and one-sample t-test p-values were calculated. Volcano
plots were generated plotting the log2 fold-change to the −log10(p) value, giving
rise to a pool of high-confidence palmitoylated proteins. It should be noted that the
median coefficient of variance (CV) from the stimulated dataset is higher (92%)
than that of the unstimulated dataset (65%). To validate the enrichment of
palmitoylated proteins under both conditions in an orthogonal way, enriched pools
were analyzed based on three criteria, described previously31: (i) previous reports in
other palmitome studies, (ii) predicted palmitoylation sites (CSSPalm 4.0), and (iii)
predicted TMDs (TMHMM 2.0)33,34.
OPPA. Purified targets (VAMP7, LAT) were diluted to 1 µM in buffer containing
50 mM NaH2PO4 (pH 6.5), 500 mM NaCl, 1 mM TCEP and 0.08% DDM. For each
time point (0, 5, 10, and 20 min), the diluted target was divided into 12 wells (50 µl
each) of a 96-well Ni-NTA-coated plate (Pierce) and allowed to bind for 1 h.
Palmitic acid alkyne (PAA)-CoA was generated by preparing 50 mM Tris (pH 8.1),
14 mM MgCl2, 0.08% DDM, 0.1 mM EDTA, 1.6 mM ATP (Roth), 400 µM coen-
zyme A (Sigma), 40 µM PAA (Avanti), 0.05 UN/ml acyl-coenzyme A synthetase
(Sigma) and 1% BSA (Sigma) and incubating at 37 °C for 1 h. This was diluted two-
fold (yielding [PAA-CoA] ~20 µM) with 0.3–2 µM purified DHHC PAT (or 1 µM
BSA for negative control) with 150 mM NaH2PO4 (pH 6.5), 300 mM NaCl and
0.08% DDM. Ni-NTA plates were washed four times with PBS+ 0.05% Tween-20
(Sigma–Aldrich) (PBST) using a plate washer (Tecan) and 100 µl of the enzyme
mixture was added. Reactions were carried out at 37 °C with shaking for designated
time points, and the reaction was quenched by washing with buffer containing
50 mM NaH2PO4 (pH 6.5), 300 mM NaCl, 40 mM NEM and 0.1% Triton X-100.
After the complete time course, plates were washed four times with PBST and click
chemistry was performed by the addition of 50 µl buffer containing 50 mM
NaH2PO4 (pH 6.5), 300 mM NaCl, and 1% Triton X-100. Click chemistry reagents
were added as described previously60; briefly, to each 50 µl, the following reagents
were added in this order, with vortexing between each step: 1 µl 1 mM biotin-azide
(Thermo Fisher) in DMSO (Sigma), 1 µl 50 mM TCEP, 3 µl 16 mM Tris[(1-benzyl-
1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (Sigma–Aldrich) prepared in 20%
DMSO and 80% t-butanol (Sigma), and 1 µl 50 mM CuSO4 (Sigma). Click
chemistry was performed at 37 °C for 3 h with shaking. After washing the plate six
times with PBST, palmitoylated targets were eluted with 100 µl buffer containing
50 mM NaH2PO4 (pH 6.5), 300 mM NaCl, 1% Triton X-100, 1 mM EDTA and
200 mM imidazole (Roth) for 30 min at 37 °C. Eluates were transferred to high-
binding plates (Greiner) coated for 3 h at room temperature with monoclonal anti-
FLAG (Sigma–Aldrich) and blocked for 2 h at room temperature with 3% BSA and
allowed to bind overnight at 4 °C with shaking. Plates were then washed six times
with PBST and buffer containing PBS and 0.2 µg/ml Eu3+-streptavidin (Perki-
nElmer) and incubated at room temperature for 1 h. After washing eight times with
PBST, fluorescence was measured in 120 µl enhancer solution (15 µM beta-
naphthoyltrifluoroacetone (Sigma), 50 µM tri-n-cotylphosphine oxide (Sigma),
6.8 mM potassium hydrogen phthalate (Roth), 100 mM acetic acid (Roth) and 0.1%
Triton X-100) using a plate reader (Victor3V, PerkinElmer) with excitation and
emission wavelengths of 340 nm and 614 nm, respectively. All measured fluores-
cence values were normalized to both the t= 0 fluorescence value and the µg of
protein (DHHC PAT or BSA) used in the reaction, and steady-state rates were
calculated over the 20-min reaction time.
Immunofluorescence. Coverslips and dishes preparation: 12mmø coverslips
(VWR, 631-0666) were precoated with 0.02% of poly-L-Lysine for 20 min at room
temperature and were washed 3 times in water before being dried and kept for
maximum 2 days. 100,000 cells were incubated on coverslips for 30 min in PBS.
Preparation of Jurkat T cells and Raji B cells conjugates: Raji B cells were
washed, resuspended at a concentration of 1 × 106 cells/mL in RPMI without FCS
and labeled with CellTracker™ Blue CMAC dye (10 µM, Thermo Fisher, C2110) for
20 min at 37 °C. Labeling was stopped with RPMI 10% FCS and cells were washed
once and resuspended at 1 × 106 cells/mL. Cells were pulsed with SEE (100 ng/mL)
or left untreated for 30 min at 37 °C before being washed once and resuspended at a
concentration of 1 × 106 cells/mL. 100,000 Raji cells were incubated on coverslips
for 30 min, washed once with warm PBS and 150,000 Jurkat cells resuspended in
RPMI 10% FCS were added for 15 min. Coverslips were washed once with cold PBS
before fixation.
Fixation: Cells were fixed with 4% paraformaldehyde (Life Technologies,
FB002) for 15 min at room temperature, washed once in PBS and excess of
paraformaldehyde was quenched for 10 min with PBS 10 mM glycine (Thermo
Fisher Scientific, G8898). Coverslips were kept at 4 °C in PBS until
permeabilization and staining.
Staining: Cells were permeabilized for 30 min at room temperature with PBS+
0.2% Bovine Serum Albumin (BSA, Euromedex, 04-100-812) and 0.05% Saponin
(Sigma–Aldrich, S4521). Cells were then incubated for 1 h at room temperature
with primary antibody, then washed three times with PBS 0.2% BSA 0.05%
Saponin and incubated protected from light for 20 min in the same buffer with
spun secondary antibodies. After washing once with PBS BSA Saponin, and once
with PBS, coverslips were soaked three times in PBS, three times in water, and
mounted on slides.
Mounting: For regular confocal microscopy, coverslips were mounted with 4–6
µL Fluoromount G (SouthernBiotech, 0100-01) on slides (KNITTEL Starfrost) and
dried overnight protected from light before microscope acquisition.
Microscope: Images were acquired with a Leica DmI8 inverted microscope
equipped with an SP8 confocal unit using either a ×40(1.35NA) or ×63(1.4NA)
objective. Single plane images or Z-stack of images were acquired (pixel size around
60 nm).
Analysis of VAMP7 colocalization with Giantin: Z-stack (0.5 μm) images of
similarly dimensioned Jurkat cells were chosen. In this z-stack, an ROI surrounding
the Golgi was defined based on Giantin staining. Within each ROI, masks based on
both Giantin and VAMP7 stainings were created by thresholding. Automatic
colocalization assays were performed with Mander’s overlap coefficient, using the
JACoP plugin for ImageJ64.
Antibodies: Anti-Flag (1/100) was from Sigma–Aldrich (F3165). Anti-Giantin
(1/100) was produced by the recombinant antibody platform of the Institut Curie,
Paris, France. Anti–rabbit Ig Alexa Fluor 488 (1/200) and anti–mouse Ig Alexa
Fluor 568 (1/200) antibodies were from Thermo Fisher Scientific (A11034 and
A11004 respectively).
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Recruitment at the immune synapse and “Mean Cell” creation: Single images
corresponding to the middle planes of conjugates were extracted from Z-stack.
T cells were cropped and oriented in the same way regarding their synapse
(script#1). Obtained T-cell images were grouped by condition (WT/C183A ± SEE)
and fluorescence intensities were normalized by the mean fluorescence intensity
(MFI). Images were then resized to the smallest image size in order to create a
normalized stack of images for each group (script#2). All groups were normalized
(size and intensity) before being compared. Stacks of aligned cells were finally
projected (averaging method) giving single plane “mean cells” (script#3). Stacks
were resized to obtain a 1-pixel height stack by averaging the fluorescence intensity
of the total height of each image. Projections of the 1-pixel resized stacks were
obtained based on average and standard deviation methods and pixel intensities
profiles were performed along projections width (script#4). In order to get a cell-
by-cell quantification, we also computed an enrichment ratio at the synapse. This
enrichment was defined as the ratio between the total cell fluorescence and the
fluorescence in the synaptic region (rectangle at the synapse representing 20% of
the total cell). (script#3).
Statistics and reproducibility. The proteomic experiments of ABE-labeled
experiments were performed with four biological replicates. Heavy/light SILAC
ratios were calculated using MaxQuant software and mean values and one-sample
t-test p-values were calculated for the volcano plot analysis. OPPA experiments
were performed with n ≥ 12 technical replicates on each plate for each time point,
and geometric means and standard errors of the mean were calculated for each
condition.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository59 with the dataset identifiers PXD018710
and PXD018703. Supplementary Data 1 contains proteins enriched via ABE in
unstimulated and/or anti-CD3/anti-CD28 costimulated (10-min) Jurkat T cells. Source
data are available as Supplementary Data 2 and 3. All other data are available from the
corresponding author on reasonable request.
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